Advanced Progress in the Role of Adipose-Derived Mesenchymal Stromal/Stem Cells in the Application of Central Nervous System Disorders
Pharmaceutics · 16.11.2023 · 15 (11) · 2637
DOI: 10.3390/pharmaceutics15112637 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 16.11.2023. Verfasst von Haiyue Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xiangya Hospital, Central South University, Changsha 410008, China. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundations for Excellent Young Scholars of Hunan Province, Key Research and Development Program of Hunan Province, Research Project on Education and Teaching Innovation of Central South University.
Abstract (Originalsprache)
Currently, adipose-derived mesenchymal stromal/stem cells (ADMSCs) are recognized as a highly promising material for stem cell therapy due to their accessibility and safety. Given the frequently irreversible damage to neural cells associated with CNS disorders, ADMSC-related therapy, which primarily encompasses ADMSC transplantation and injection with exosomes derived from ADMSCs or secretome, has the capability to inhibit inflammatory response and neuronal apoptosis, promote neural regeneration, as well as modulate immune responses, holding potential as a comprehensive approach to treat CNS disorders and improve prognosis. Empirical evidence from both experiments and clinical trials convincingly demonstrates the satisfactory safety and efficacy of ADMSC-related therapies. This review provides a systematic summary of the role of ADMSCs in the treatment of central nervous system (CNS) disorders and explores their therapeutic potential for clinical application. ADMSC-related therapy offers a promising avenue to mitigate damage and enhance neurological function in central nervous system (CNS) disorders. However, further research is necessary to establish the safety and efficacy of clinical ADMSC-based therapy, optimize targeting accuracy, and refine delivery approaches for practical applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Xiangya Hospital, Central South University, Changsha 410008, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China.
ORCID-Profile: Yishu Fan
Förderung
- Natural Science Foundations for Excellent Young Scholars of Hunan Province
- Key Research and Development Program of Hunan Province
- Research Project on Education and Teaching Innovation of Central South University
- Natural Science Foundations of Hunan Province
- National Natural Science Foundation of China
Zitieren
APA
Wu, H., Fan, Y., & Zhang, M. (2023). Advanced Progress in the Role of Adipose-Derived Mesenchymal Stromal/Stem Cells in the Application of Central Nervous System Disorders. Pharmaceutics, 15(11), 2637. https://doi.org/10.3390/pharmaceutics15112637
Vancouver
Wu H, Fan Y, Zhang M. Advanced Progress in the Role of Adipose-Derived Mesenchymal Stromal/Stem Cells in the Application of Central Nervous System Disorders. Pharmaceutics. 2023;15(11):2637. doi:10.3390/pharmaceutics15112637
BibTeX
@article{Wu2023,
author = {Wu, Haiyue and Fan, Yishu and Zhang, Mengqi},
title = {Advanced Progress in the Role of Adipose-Derived Mesenchymal Stromal/Stem Cells in the Application of Central Nervous System Disorders},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {11},
pages = {2637},
doi = {10.3390/pharmaceutics15112637}
}
EUVIMED